Valeo PharmaVP2 
$0.010.00%24h
0.00%24h
Global rank
Market cap$450.97K
Change 7d0.00%
YTD Performance-94.87%
SP500 benchmarkUnderperform
P/E-0.02
P/S0.01
Revenue$37.91M
Earnings-$19.56M
Dividend yield-
Main Sector
Healthcare
EPS for Valeo Pharma (VP2)
Valeo Pharma has an EPS of $-0.32. In 2022, the company made an earnings per share (EPS) of $-0.32. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for VP2
-
Value:-
EPS history for Valeo Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.32 | 0.00% |
| 2022 | -$0.32 | 60.00% |
| 2021 | -$0.2 | 150.00% |
| 2020 | -$0.08 | - |
View the highest EPS stocks
